1 Study Coverage 1.1 Artemisinin Derivatives Product Introduction 1.2 Market by Type 1.2.1 Global Artemisinin Derivatives Market Size Growth Rate by Type 1.2.2 Dihydroartemisinin 1.2.3 Artemisunate 1.2.4 Others 1.3 Market by Application 1.3.1 Global Artemisinin Derivatives Market Size Growth Rate by Application 1.3.2 Malaria Treatment 1.3.3 Scientific Research 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Artemisinin Derivatives Market Size, Estimates and Forecasts 2.1.1 Global Artemisinin Derivatives Revenue 2016-2027 2.1.2 Global Artemisinin Derivatives Sales 2016-2027 2.2 Global Artemisinin Derivatives, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Artemisinin Derivatives Historical Market Size by Region (2016-2021) 2.3.1 Global Artemisinin Derivatives Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Artemisinin Derivatives Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Artemisinin Derivatives Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Artemisinin Derivatives Sales Forecast by Region (2022-2027) 2.4.2 Global Artemisinin Derivatives Revenue Forecast by Region (2022-2027) 3 Global Artemisinin Derivatives Competitor Landscape by Players 3.1 Global Top Artemisinin Derivatives Manufacturers by Sales 3.1.1 Global Artemisinin Derivatives Sales by Manufacturer (2016-2021) 3.1.2 Global Artemisinin Derivatives Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Artemisinin Derivatives Manufacturers by Revenue 3.2.1 Key Artemisinin Derivatives Manufacturers Covered: Ranking by Revenue 3.2.2 Global Artemisinin Derivatives Revenue by Manufacturers (2016-2021) 3.2.3 Global Artemisinin Derivatives Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Artemisinin Derivatives Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Artemisinin Derivatives Revenue in 2020 3.2.6 Global Artemisinin Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Artemisinin Derivatives Price by Manufacturers 3.4 Global Artemisinin Derivatives Manufacturing Base Distribution, Product Types 3.4.1 Artemisinin Derivatives Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Artemisinin Derivatives Product Type 3.4.3 Date of International Manufacturers Enter into Artemisinin Derivatives Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Artemisinin Derivatives Market Size by Type (2016-2021) 4.1.1 Global Artemisinin Derivatives Sales by Type (2016-2021) 4.1.2 Global Artemisinin Derivatives Revenue by Type (2016-2021) 4.1.3 Artemisinin Derivatives Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Artemisinin Derivatives Market Size Forecast by Type (2022-2027) 4.2.1 Global Artemisinin Derivatives Sales Forecast by Type (2022-2027) 4.2.2 Global Artemisinin Derivatives Revenue Forecast by Type (2022-2027) 4.2.3 Artemisinin Derivatives Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Artemisinin Derivatives Market Size by Application (2016-2021) 5.1.1 Global Artemisinin Derivatives Sales by Application (2016-2021) 5.1.2 Global Artemisinin Derivatives Revenue by Application (2016-2021) 5.1.3 Artemisinin Derivatives Price by Application (2016-2021) 5.2 Artemisinin Derivatives Market Size Forecast by Application (2022-2027) 5.2.1 Global Artemisinin Derivatives Sales Forecast by Application (2022-2027) 5.2.2 Global Artemisinin Derivatives Revenue Forecast by Application (2022-2027) 5.2.3 Global Artemisinin Derivatives Price Forecast by Application (2022-2027) 6 United States by Players, Type and Application 6.1 United States Artemisinin Derivatives Market Size YoY Growth 2016-2027 6.1.1 United States Artemisinin Derivatives Sales YoY Growth 2016-2027 6.1.2 United States Artemisinin Derivatives Revenue YoY Growth 2016-2027 6.1.3 United States Artemisinin Derivatives Market Share in Global Market 2016-2027 6.2 United States Artemisinin Derivatives Market Size by Players (International and Local Players) 6.2.1 United States Top Artemisinin Derivatives Players by Sales (2016-2021) 6.2.2 United States Top Artemisinin Derivatives Players by Revenue (2016-2021) 6.3 United States Artemisinin Derivatives Historic Market Review by Type (2016-2021) 6.3.1 United States Artemisinin Derivatives Sales Market Share by Type (2016-2021) 6.3.2 United States Artemisinin Derivatives Revenue Market Share by Type (2016-2021) 6.3.3 United States Artemisinin Derivatives Price by Type (2016-2021) 6.4 United States Artemisinin Derivatives Market Estimates and Forecasts by Type (2022-2027) 6.4.1 United States Artemisinin Derivatives Sales Forecast by Type (2022-2027) 6.4.2 United States Artemisinin Derivatives Revenue Forecast by Type (2022-2027) 6.4.3 United States Artemisinin Derivatives Price Forecast by Type (2022-2027) 6.5 United States Artemisinin Derivatives Historic Market Review by Application (2016-2021) 6.5.1 United States Artemisinin Derivatives Sales Market Share by Application (2016-2021) 6.5.2 United States Artemisinin Derivatives Revenue Market Share by Application (2016-2021) 6.5.3 United States Artemisinin Derivatives Price by Application (2016-2021) 6.6 United States Artemisinin Derivatives Market Estimates and Forecasts by Application (2022-2027) 6.6.1 United States Artemisinin Derivatives Sales Forecast by Application (2022-2027) 6.6.2 United States Artemisinin Derivatives Revenue Forecast by Application (2022-2027) 6.6.3 United States Artemisinin Derivatives Price Forecast by Application (2022-2027) 7 North America 7.1 North America Artemisinin Derivatives Market Size YoY Growth 2016-2027 7.2 North America Artemisinin Derivatives Market Facts & Figures by Country 7.2.1 North America Artemisinin Derivatives Sales by Country (2016-2021) 7.2.2 North America Artemisinin Derivatives Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Artemisinin Derivatives Market Size YoY Growth 2016-2027 8.2 Asia Pacific Artemisinin Derivatives Market Facts & Figures by Region 8.2.1 Asia Pacific Artemisinin Derivatives Sales by Region (2016-2021) 8.2.2 Asia Pacific Artemisinin Derivatives Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Artemisinin Derivatives Market Size YoY Growth 2016-2027 9.2 Europe Artemisinin Derivatives Market Facts & Figures by Country 9.2.1 Europe Artemisinin Derivatives Sales by Country (2016-2021) 9.2.2 Europe Artemisinin Derivatives Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Artemisinin Derivatives Market Size YoY Growth 2016-2027 10.2 Latin America Artemisinin Derivatives Market Facts & Figures by Country 10.2.1 Latin America Artemisinin Derivatives Sales by Country (2016-2021) 10.2.2 Latin America Artemisinin Derivatives Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Artemisinin Derivatives Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Artemisinin Derivatives Market Facts & Figures by Country 11.2.1 Middle East and Africa Artemisinin Derivatives Sales by Country (2016-2021) 11.2.2 Middle East and Africa Artemisinin Derivatives Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Sanofi 12.1.1 Sanofi Corporation Information 12.1.2 Sanofi Description and Business Overview 12.1.3 Sanofi Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Sanofi Artemisinin Derivatives Products Offered 12.1.5 Sanofi Recent Development 12.2 KPC Pharmaceuticals 12.2.1 KPC Pharmaceuticals Corporation Information 12.2.2 KPC Pharmaceuticals Description and Business Overview 12.2.3 KPC Pharmaceuticals Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.2.4 KPC Pharmaceuticals Artemisinin Derivatives Products Offered 12.2.5 KPC Pharmaceuticals Recent Development 12.3 Guangxi Xiancaotang Pharmaceutical 12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information 12.3.2 Guangxi Xiancaotang Pharmaceutical Description and Business Overview 12.3.3 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Products Offered 12.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development 12.4 Guilin Pharmaceutical 12.4.1 Guilin Pharmaceutical Corporation Information 12.4.2 Guilin Pharmaceutical Description and Business Overview 12.4.3 Guilin Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Guilin Pharmaceutical Artemisinin Derivatives Products Offered 12.4.5 Guilin Pharmaceutical Recent Development 12.5 Kerui Nanhai Pharmaceutical 12.5.1 Kerui Nanhai Pharmaceutical Corporation Information 12.5.2 Kerui Nanhai Pharmaceutical Description and Business Overview 12.5.3 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Kerui Nanhai Pharmaceutical Artemisinin Derivatives Products Offered 12.5.5 Kerui Nanhai Pharmaceutical Recent Development 12.6 Shanghai Natural Bio-engineering Co 12.6.1 Shanghai Natural Bio-engineering Co Corporation Information 12.6.2 Shanghai Natural Bio-engineering Co Description and Business Overview 12.6.3 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Shanghai Natural Bio-engineering Co Artemisinin Derivatives Products Offered 12.6.5 Shanghai Natural Bio-engineering Co Recent Development 12.7 Novanat Bioresource 12.7.1 Novanat Bioresource Corporation Information 12.7.2 Novanat Bioresource Description and Business Overview 12.7.3 Novanat Bioresource Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Novanat Bioresource Artemisinin Derivatives Products Offered 12.7.5 Novanat Bioresource Recent Development 12.8 Botanical Extracts EPZ Ltd 12.8.1 Botanical Extracts EPZ Ltd Corporation Information 12.8.2 Botanical Extracts EPZ Ltd Description and Business Overview 12.8.3 Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Botanical Extracts EPZ Ltd Artemisinin Derivatives Products Offered 12.8.5 Botanical Extracts EPZ Ltd Recent Development 12.11 Sanofi 12.11.1 Sanofi Corporation Information 12.11.2 Sanofi Description and Business Overview 12.11.3 Sanofi Artemisinin Derivatives Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Sanofi Artemisinin Derivatives Products Offered 12.11.5 Sanofi Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Artemisinin Derivatives Industry Trends 13.2 Artemisinin Derivatives Market Drivers 13.3 Artemisinin Derivatives Market Challenges 13.4 Artemisinin Derivatives Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Artemisinin Derivatives Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Artemisinin Derivatives Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Dihydroartemisinin Table 3. Major Manufacturers of Artemisunate Table 4. Major Manufacturers of Others Table 5. Global Artemisinin Derivatives Market Size Growth Rate by Application (2021-2027) & (K MT) Table 6. Global Artemisinin Derivatives Market Size by Region (K MT) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Artemisinin Derivatives Sales by Regions (2016-2021) & (K MT) Table 8. Global Artemisinin Derivatives Sales Market Share by Regions (2016-2021) Table 9. Global Artemisinin Derivatives Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Artemisinin Derivatives Sales Forecast by Region (2022-2027) & (K MT) Table 11. Global Artemisinin Derivatives Sales Market Share Forecast by Region (2022-2027) Table 12. Global Artemisinin Derivatives Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Artemisinin Derivatives Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Artemisinin Derivatives Sales by Manufacturers (2016-2021) (K MT) Table 15. Global Artemisinin Derivatives Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Artemisinin Derivatives Manufacturers by Revenue (US$ Million) in 2020 Table 17. Artemisinin Derivatives Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Artemisinin Derivatives Revenue Share by Manufacturers (2016-2021) Table 19. Global Artemisinin Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Artemisinin Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinin Derivatives as of 2020) Table 21. Key Manufacturers Artemisinin Derivatives Price (2016-2021) (USD/MT) Table 22. Artemisinin Derivatives Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Artemisinin Derivatives Product Type Table 24. Date of International Manufacturers Enter into Artemisinin Derivatives Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Artemisinin Derivatives Sales by Type (2016-2021) (K MT) Table 27. Global Artemisinin Derivatives Sales Share by Type (2016-2021) Table 28. Global Artemisinin Derivatives Revenue by Type (2016-2021) (US$ Million) Table 29. Global Artemisinin Derivatives Revenue Share by Type (2016-2021) Table 30. Artemisinin Derivatives Average Selling Price (ASP) by Type (2016-2021) & (USD/MT) Table 31. Global Artemisinin Derivatives Sales Forecast by Type (2022-2027) & (K MT) Table 32. Global Artemisinin Derivatives Sales Market Share Forecast by Type (2022-2027) Table 33. Global Artemisinin Derivatives Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Artemisinin Derivatives Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Artemisinin Derivatives Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT) Table 36. Global Artemisinin Derivatives Sales by Application (2016-2021) (K MT) Table 37. Global Artemisinin Derivatives Sales Share by Application (2016-2021) Table 38. Global Artemisinin Derivatives Revenue by Application (2016-2021) (US$ Million) Table 39. Global Artemisinin Derivatives Revenue Share by Application (2016-2021) Table 40. Artemisinin Derivatives Average Selling Price (ASP) by Application (2016-2021) & (USD/MT) Table 41. Global Artemisinin Derivatives Sales Forecast by Application (2022-2027) & (K MT) Table 42. Global Artemisinin Derivatives Sales Market Share Forecast by Application (2022-2027) Table 43. Global Artemisinin Derivatives Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Artemisinin Derivatives Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Artemisinin Derivatives Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT) Table 46. United States Artemisinin Derivatives Sales (K MT) of Key Companies (2016-2021) Table 47. United States Artemisinin Derivatives Sales Share by Company (2016-2021) Table 48. United States Artemisinin Derivatives Revenue (US$ Million) by Company (2016-2021) Table 49. United States Artemisinin Derivatives Revenue Share by Company (2016-2021) Table 50. United States Artemisinin Derivatives Sales (K MT) by Type (2016-2021) Table 51. United States Artemisinin Derivatives Sales Share by Type (2016-2021) Table 52. United States Artemisinin Derivatives Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. United States Artemisinin Derivatives Price (USD/MT) by Type (2016-2021) Table 54. United States Artemisinin Derivatives Sales (K MT) by Type (2022-2027) Table 55. United States Artemisinin Derivatives Sales Share by Type (2022-2027) Table 56. United States Artemisinin Derivatives Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. United States Artemisinin Derivatives Revenue Share by Type (2022-2027) Table 58. United States Artemisinin Derivatives Price (USD/MT) by Type (2022-2027) Table 59. United States Artemisinin Derivatives Sales (K MT) by Application (2016-2021) Table 60. United States Artemisinin Derivatives Sales Share by Application (2016-2021) Table 61. United States Artemisinin Derivatives Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. United States Artemisinin Derivatives Price (USD/MT) by Application (2016-2021) Table 63. United States Artemisinin Derivatives Sales (K MT) by Application (2022-2027) Table 64. United States Artemisinin Derivatives Sales Share by Application (2022-2027) Table 65. United States Artemisinin Derivatives Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. United States Artemisinin Derivatives Revenue Share by Application (2022-2027) Table 67. United States Artemisinin Derivatives Price (USD/MT) by Application (2022-2027) Table 68. North America Artemisinin Derivatives Sales by Country (2016-2021) & (K MT) Table 69. North America Artemisinin Derivatives Sales Market Share by Country (2016-2021) Table 70. North America Artemisinin Derivatives Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Artemisinin Derivatives Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Artemisinin Derivatives Sales by Region (2016-2021) & (K MT) Table 73. Asia Pacific Artemisinin Derivatives Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Artemisinin Derivatives Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Artemisinin Derivatives Revenue Market Share by Region (2016-2021) Table 76. Europe Artemisinin Derivatives Sales by Country (2016-2021) & (K MT) Table 77. Europe Artemisinin Derivatives Sales Market Share by Country (2016-2021) Table 78. Europe Artemisinin Derivatives Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Artemisinin Derivatives Revenue Market Share by Country (2016-2021) Table 80. Latin America Artemisinin Derivatives Sales by Country (2016-2021) & (K MT) Table 81. Latin America Artemisinin Derivatives Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Artemisinin Derivatives Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Artemisinin Derivatives Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Artemisinin Derivatives Sales by Country (2016-2021) & (K MT) Table 85. Middle East and Africa Artemisinin Derivatives Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Artemisinin Derivatives Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Artemisinin Derivatives Revenue Market Share by Country (2016-2021) Table 88. Sanofi Corporation Information Table 89. Sanofi Description and Business Overview Table 90. Sanofi Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 91. Sanofi Artemisinin Derivatives Product Table 92. Sanofi Recent Development Table 93. KPC Pharmaceuticals Corporation Information Table 94. KPC Pharmaceuticals Description and Business Overview Table 95. KPC Pharmaceuticals Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 96. KPC Pharmaceuticals Product Table 97. KPC Pharmaceuticals Recent Development Table 98. Guangxi Xiancaotang Pharmaceutical Corporation Information Table 99. Guangxi Xiancaotang Pharmaceutical Description and Business Overview Table 100. Guangxi Xiancaotang Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 101. Guangxi Xiancaotang Pharmaceutical Product Table 102. Guangxi Xiancaotang Pharmaceutical Recent Development Table 103. Guilin Pharmaceutical Corporation Information Table 104. Guilin Pharmaceutical Description and Business Overview Table 105. Guilin Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 106. Guilin Pharmaceutical Product Table 107. Guilin Pharmaceutical Recent Development Table 108. Kerui Nanhai Pharmaceutical Corporation Information Table 109. Kerui Nanhai Pharmaceutical Description and Business Overview Table 110. Kerui Nanhai Pharmaceutical Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 111. Kerui Nanhai Pharmaceutical Product Table 112. Kerui Nanhai Pharmaceutical Recent Development Table 113. Shanghai Natural Bio-engineering Co Corporation Information Table 114. Shanghai Natural Bio-engineering Co Description and Business Overview Table 115. Shanghai Natural Bio-engineering Co Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 116. Shanghai Natural Bio-engineering Co Product Table 117. Shanghai Natural Bio-engineering Co Recent Development Table 118. Novanat Bioresource Corporation Information Table 119. Novanat Bioresource Description and Business Overview Table 120. Novanat Bioresource Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 121. Novanat Bioresource Product Table 122. Novanat Bioresource Recent Development Table 123. Botanical Extracts EPZ Ltd Corporation Information Table 124. Botanical Extracts EPZ Ltd Description and Business Overview Table 125. Botanical Extracts EPZ Ltd Artemisinin Derivatives Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 126. Botanical Extracts EPZ Ltd Product Table 127. Botanical Extracts EPZ Ltd Recent Development Table 128. Artemisinin Derivatives Market Trends Table 129. Artemisinin Derivatives Market Drivers Table 130. Artemisinin Derivatives Market Challenges Table 131. Artemisinin Derivatives Market Restraints Table 132. Artemisinin Derivatives Customers List Table 133. Artemisinin Derivatives Distributors List Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Artemisinin Derivatives Product Picture Figure 2. Global Artemisinin Derivatives Sales Market Share by Type in 2020 & 2027 Figure 3. Dihydroartemisinin Product Picture Figure 4. Artemisunate Product Picture Figure 5. Others Product Picture Figure 6. Global Artemisinin Derivatives Sales Market Share by Application in 2020 & 2027 Figure 7. Malaria Treatment Figure 8. Scientific Research Figure 9. Others Figure 10. Artemisinin Derivatives Report Years Considered Figure 11. Global Artemisinin Derivatives Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Artemisinin Derivatives Market Size 2016-2027 (US$ Million) Figure 13. Global Artemisinin Derivatives Sales 2016-2027 (K MT) Figure 14. Global Artemisinin Derivatives Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Artemisinin Derivatives Sales Market Share by Region (2016-2021) Figure 16. Global Artemisinin Derivatives Sales Market Share by Region in 2020 Figure 17. Global Artemisinin Derivatives Revenue Market Share by Region (2016-2021) Figure 18. Global Artemisinin Derivatives Revenue Market Share by Region in 2020 Figure 19. Global Artemisinin Derivatives Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Artemisinin Derivatives Revenue in 2020 Figure 21. Artemisinin Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Artemisinin Derivatives Sales Market Share by Type (2016-2021) Figure 23. Global Artemisinin Derivatives Sales Market Share by Type in 2020 Figure 24. Global Artemisinin Derivatives Revenue Market Share by Type (2016-2021) Figure 25. Global Artemisinin Derivatives Revenue Market Share by Type in 2020 Figure 26. Global Artemisinin Derivatives Sales Market Share by Application (2016-2021) Figure 27. Global Artemisinin Derivatives Sales Market Share by Application in 2020 Figure 28. Global Artemisinin Derivatives Revenue Market Share by Application (2016-2021) Figure 29. Global Artemisinin Derivatives Revenue Market Share by Application in 2020 Figure 30. United States Artemisinin Derivatives Sales Growth Rate 2016-2027 (K MT) Figure 31. United States Artemisinin Derivatives Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. United States Artemisinin Derivatives Market Share in Global Market 2016-2027 Figure 33. United States 5 and 10 Largest Artemisinin Derivatives Players Market Share by Revenue in Artemisinin Derivatives in 2020 Figure 34. United States Artemisinin Derivatives Revenue Share by Type (2016-2021) Figure 35. United States Artemisinin Derivatives Revenue Growth Rate by Type in 2016 & 2020 Figure 36. United States Artemisinin Derivatives Revenue Share by Application (2016-2021) Figure 37. United States Artemisinin Derivatives Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Artemisinin Derivatives Sales Growth Rate 2016-2021 (K MT) Figure 39. North America Artemisinin Derivatives Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Artemisinin Derivatives Sales Market Share by Country in 2020 Figure 41. North America Artemisinin Derivatives Revenue Market Share by Country in 2020 Figure 42. U.S. Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 43. U.S. Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 45. Canada Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Artemisinin Derivatives Sales Growth Rate 2016-2021 (K MT) Figure 47. Europe Artemisinin Derivatives Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Artemisinin Derivatives Sales Market Share by Country in 2020 Figure 49. Europe Artemisinin Derivatives Revenue Market Share by Country in 2020 Figure 50. Germany Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 51. Germany Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 53. France Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 55. U.K. Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 57. Italy Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 59. Russia Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Artemisinin Derivatives Sales Growth Rate 2016-2021 (K MT) Figure 61. Asia Pacific Artemisinin Derivatives Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Artemisinin Derivatives Sales Market Share by Region in 2020 Figure 63. Asia Pacific Artemisinin Derivatives Revenue Market Share by Region in 2020 Figure 64. China Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 65. China Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 67. Japan Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 69. South Korea Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 71. India Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 73. Australia Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 75. Taiwan Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 77. Indonesia Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 79. Thailand Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 81. Malaysia Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 83. Philippines Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 85. Vietnam Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Artemisinin Derivatives Sales Growth Rate 2016-2021 (K MT) Figure 87. Latin America Artemisinin Derivatives Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Artemisinin Derivatives Sales Market Share by Country in 2020 Figure 89. Latin America Artemisinin Derivatives Revenue Market Share by Country in 2020 Figure 90. Mexico Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 91. Mexico Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 93. Brazil Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 95. Argentina Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Artemisinin Derivatives Sales Growth Rate 2016-2021 (K MT) Figure 97. Middle East and Africa Artemisinin Derivatives Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Artemisinin Derivatives Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Artemisinin Derivatives Revenue Market Share by Country in 2020 Figure 100. Turkey Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 101. Turkey Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 103. Saudi Arabia Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. U.A.E Artemisinin Derivatives Sales Growth Rate (2016-2021) (K MT) Figure 105. U.A.E Artemisinin Derivatives Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Artemisinin Derivatives Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Sanofi KPC Pharmaceuticals Guangxi Xiancaotang Pharmaceutical Guilin Pharmaceutical Kerui Nanhai Pharmaceutical Shanghai Natural Bio-engineering Co Novanat Bioresource Botanical Extracts EPZ Ltd